Europe Plasma Fractionation Market Share and Forecast by 2028

Europe Plasma Fractionation Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Immunoglobulin, Albumin, Coagulation Factor Concentrates, Protease Inhibitors, and Other Plasma Products), Application (Neurology, Immunology, Hematology, Critical Care, Pulmonology, and Other Applications), and End User (Hospitals and Clinics, Clinical Research Laboratories, and Academic Institutes)

Report Date : Dec 2021
Report Code : TIPRE00026271

Category : Life Sciences
Status : Published

Available Report Formats :
No. of Pages : 133

The plasma fractionation market in Europe is expected to grow from US$ 6,824.67 million in 2021 to US$ 10,402.95 million by 2028; it is estimated to grow at a CAGR of 6.2% from 2021 to 2028.

France, Germany, Italy, Spain, and the UK are major economies in Europe. the market offers considerable potential for the companies operating the market-related businesses. Due to the positive market growth, the Europe and regional market players are actively adopting organic and inorganic development strategies. Thus, it is expected to attract more significant investments in the market in the forecast period. For example, in August 2021, Biotest AG started about the sixth plasma collection center in the Czech Republic. The company received the operating license for these centers from the national public health authority SUKL. The center is state-of-the-art with about 15 donor beds and has facilities for the donors such as television, Wi-Fi, and others. The center is operational six days a week for twelve hours a day. Hence, fast market development owing to active participation of market players is the major factor driving the growth of the Europe plasma fractionation market.

In European countries, the medical practice of various chronic diseases such as neurological disorders, hematological disorders, and respiratory diseases has changed. Due to the diversification of the medical staff and the decision to focus on treating the critically ill, rising COVID-19 has impacted illness detection and treatment. Due to the current pandemic, many research organizations are focusing more on COVID-19 studies and are working hard to understand the virus better. Some of the federal agencies in the region have taken the initiative to adopt plasma therapy to treat COVID-19 patients. For instance, the National Agency for Medicines and Health Products Safety of France (ANSM) announced that immune plasma therapy would be used in treating critically ill patients. Also, the European Commission recommended the emergency use of convalescent plasma therapy to treat critical patients. Thus, the use of plasma therapies in the management of COVID-19 has positively impacted the market to some extent. However, due to COVID-19, the overall medical practice of neurological disorders, hematological disorders, and idiosyncratic disorders has changed, and the majority of pharmaceutical and biopharmaceutical companies are emphasizing on developing novel treatment therapies for COVID-19, which is negatively impacting the market growth.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe plasma fractionation market. The Europe plasma fractionation market is expected to grow at a good CAGR during the forecast period.

Europe Plasma FractionationMarket Revenue and Forecast to 2028 (US$ Million)

Europe Plasma Fractionation Market Segmentation

Europe Plasma Fractionation Market – By Product

Immunoglobulin
- Intravenous Immunoglobulin (IVIG)
- Subcutaneous Immunoglobulin (SCIG)
- Albumin
Coagulation Factor Concentrates
Protease Inhibitors
Other

Europe Plasma Fractionation Market – By Application

Neurology
Immunology
Hematology
Critical Care
Pulmonology
Others

Europe Plasma Fractionation Market – By End User

Hospitals and Clinics
Clinical Research Laboratories
Academic Institutes

Europe Plasma Fractionation Market, by Country

France
Germany
Italy
Spain
UK
Rest of Europe

Europe Plasma Fractionation Market - Companies Mentioned

Bharat Serums and Vaccines Limited (BSV)
Bio Products Laboratory Ltd.
Biotest AG.
CSL Limited
Grifols, S.A.
Kedrion S.p.A
Octapharma AG
Sanquin
SK Plasma

Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered

This text is related
to segments covered.

Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope

This text is related
to country scope.

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Plasma Fractionation Market – By Product

1.3.2 Europe Plasma Fractionation Market – By Application

1.3.3 Europe Plasma Fractionation Market – By End User

1.3.4 Europe Plasma Fractionation Market – By Country

2. Europe Plasma Fractionation Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Plasma Fractionation Market – Market Landscape

4.1 Overview

4.2 Europe PEST Analysis

4.3 Experts Opinion

5. Europe Plasma Fractionation Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Plasma Therapy Being Widely Used

5.1.2 Market is Developing Due to Active Participation of the Key Players

5.2 Market Restraints

5.2.1 Alternate Non-Plasma Substitutes Available

5.3 Future Trends

5.3.1 Novel Diseases Getting Treated By Using Plasma Therapy

5.4 Impact Analysis

6. Plasma Fractionation Market – Europe Analysis

6.1 Europe Plasma Fractionation Market Revenue Forecast and Analysis

7. Europe Plasma Fractionation Market Revenue and Forecasts To 2028– by Product

7.1 Overview

7.2 Europe Plasma Fractionation Market, By Product 2021 & 2028 (%)

7.3 Immunoglobulin

7.3.1 Overview

7.3.2 Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.2.1 Intravenous Immunoglobulin (IVIG)

7.3.2.1.1 Overview

7.3.2.1.2 Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.2.2 Subcutaneous Immunoglobulin (SCIG)

7.3.2.2.1 Overview

7.3.2.2.2 Subcutaneous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.4 Albumin

7.4.1 Overview

7.4.2 Albumin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.5 Coagulation Factor Concentrates

7.5.1 Overview

7.5.2 Coagulation Factor Concentrates: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.6 Protease Inhibitors

7.6.1 Overview

7.6.2 Protease Inhibitors: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.7 Other Plasma Products

7.7.1 Overview

7.7.2 Other Plasma Products: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

8. Europe Plasma Fractionation Market Revenue and Forecasts To 2028 – Application

8.1 Overview

8.2 Europe Plasma Fractionation Market Share by Application 2021 & 2028 (%)

8.3 Neurology

8.3.1 Overview

8.3.2 Neurology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

8.4 Immunology

8.4.1 Overview

8.4.2 Immunology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

8.5 Hematology

8.5.1 Overview

8.5.2 Hematology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

8.6 Critical Care

8.6.1 Overview

8.6.2 Critical Care: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

8.7 Pulmonology

8.7.1 Overview

8.7.2 Pulmonology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

8.8 Other Applications

8.8.1 Overview

8.8.2 Other Applications: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

9. Europe Plasma Fractionation Market Revenue and Forecasts To 2028 – End User

9.1 Overview

9.2 Europe Plasma Fractionation Market Share by End User 2021 & 2028 (%)

9.3 Hospitals and Clinics

9.3.1 Overview

9.3.2 Hospitals and Clinics: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

9.4 Clinical Research Laboratories

9.4.1 Overview

9.4.2 Clinical Research Laboratories: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

9.5 Academic Institutes

9.5.1 Overview

9.5.2 Academic Institutes: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

10. Europe Plasma Fractionation Market Revenue and Forecasts to 2028 – Country Analysis

10.1 Overview

10.1.1 Europe: Plasma Fractionation Market, by Country, 2021 & 2028 (%)

10.1.1.1 Germany: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 Overview

10.1.1.1.2 Germany: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.3 Germany: Plasma Fractionation Market, by Product– Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.3.1 Germany: Plasma Fractionation Market, by Immunoglobulin Type– Revenue and Forecast to 2028 (USD Million)

10.1.1.1.4 Germany: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.5 Germany: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2 France: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Overview

10.1.1.2.2 France: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.3 France: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.3.1 France: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.4 France: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.5 France: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3 UK: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 Overview

10.1.1.3.2 UK: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.3 UK: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.3.1 UK: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.4 UK: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.5 UK: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4 Spain: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1 Overview

10.1.1.4.2 Spain: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.3 Spain: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.3.1 Spain: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.4 Spain: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.5 Spain: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5 Italy: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.1 Overview

10.1.1.5.2 Italy: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.3 Italy: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.3.1 Italy: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)

10.1.1.5.4 Italy: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.5 Italy: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6 Rest of Europe: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.1 Overview

10.1.1.6.2 Rest of Europe: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.3 Rest of Europe: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.3.1 Rest of Europe: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.4 Rest of Europe: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.5 Rest of Europe: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)

11. Impact Of COVID-19 Pandemic on Europe Plasma Fractionation Market

11.1 Europe: Impact Assessment Of COVID-19 Pandemic

12. Plasma Fractionation Market–Industry Landscape

12.1 Overview

12.2 Growth Strategies Followed by Major Market Players (%)

12.3 Organic Developments

12.3.1 Overview

12.4 Inorganic developments

12.4.1 Overview

13. Company Profiles

13.1 Biotest AG.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Octapharma AG

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Kedrion S.p.A

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 CSL Limited

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Grifols, S.A.

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Bio Products Laboratory Ltd.

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Sanquin

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Bharat Serums and Vaccines Limited (BSV)

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 SK Plasma

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. Germany: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 2. Germany: Plasma Fractionation Market, by Immunoglobulin Type– Revenue and Forecast to 2028 (USD Million)

Table 3. Germany: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 4. Germany: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 5. France: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 6. France: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)

Table 7. France: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 8. France: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 9. UK: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 10. UK: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)

Table 11. UK: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 12. UK: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 13. Spain: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 14. Spain: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)

Table 15. Spain: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 16. Spain: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 17. Italy: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 18. Italy: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)

Table 19. Italy: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 20. Italy: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 21. Rest of Europe: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 22. Rest of Europe: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)

Table 23. Rest of Europe: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 24. Rest of Europe: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 25. Organic Developments Done By Companies

Table 26. Inorganic developments done by Companies

Table 27. Glossary of Terms, Plasma Fractionation Market

LIST OF FIGURES

Figure 1. Europe Plasma Fractionation Market Segmentation

Figure 2. Europe Plasma Fractionation Market Segmentation, By Country

Figure 3. Europe Plasma Fractionation Market Overview

Figure 4. Immunoglobulin Segment Held the Largest Share of the Product Segment in Europe Plasma Fractionation Market

Figure 5. Germany to Show Significant Growth During Forecast Period

Figure 6. Europe and PEST Analysis

Figure 7. Impact Analysis of Drivers and Restraints Pertaining to Europe Plasma Fractionation Market

Figure 8. Europe Plasma Fractionation Market – Revenue Forecast and Analysis – 2019- 2028

Figure 9. Europe Plasma Fractionation Market, by Product 2021 & 2028 (%)

Figure 10. Europe Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 11. Europe Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12. Europe Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 13. Europe Albumin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14. Europe Coagulation Factor Concentrates: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 15. Europe Protease Inhibitors: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)

Figure 16. Europe Other Plasma Products: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17. Europe Plasma Fractionation Market Share by Application 2021 & 2028 (%)

Figure 18. Europe Neurology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 19. Europe Immunology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 20. Europe Hematology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 21. Europe Critical Care: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 22. Europe Pulmonology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 23. Europe Other Applications: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 24. Europe Plasma Fractionation Market Share by End User 2021 & 2028 (%)

Figure 25. Europe Hospitals and Clinics: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 26. Europe Clinical Research Laboratories: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 27. Europe Academic Institutes: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 28. Europe: Plasma Fractionation Market, by Key Country – Revenue (2021) (USD Million)

Figure 29. Europe: Plasma Fractionation Market, by Country, 2021 & 2028 (%)

Figure 30. Germany: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

Figure 31. France: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

Figure 32. UK: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

Figure 33. Spain: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

Figure 34. Italy: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

Figure 35. Rest of Europe: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

Figure 36. Impact of COVID-19 Pandemic in European Country Markets

Figure 37. Growth Strategies Followed by Major Market Players (%)

Your Key Concerns Addressed - Question & Answer

Can I view a sample of the report before purchasing?

Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

Is analyst support included with the purchase?

Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

What are the next steps once I place an order?

Once your order is successfully placed, you will receive a confirmation email along with your invoice.

• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

Can the report be tailored to suit my specific needs?

We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.

In what format is the report delivered?

The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

How secure is the payment process on your platform?

Our payment process is fully secure and PCI-DSS compliant.

We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.

Do you provide special pricing for buying multiple reports?

Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.

Can I connect with your team to discuss the report before buying?

Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

Will I get a billing invoice upon purchase?

Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.

Is there support available if I can't access my report?

Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
Validates and strengthens in-house secondary research findings
Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

Industry participants: VPs, business development managers, market intelligence managers and national sales managers
Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.